Paper42787134PubMed
Hyperglycaemia-induced molecular reprogramming of proximal tubular epithelial cells and its contribution to diabetic kidney disease progression-a narrative review.
Gbaa T. Front Cell Dev Biol, 2026.
Cite this record
ConductScience Library. Hyperglycaemia-induced molecular reprogramming of proximal tubular epithelial cells and its contribution to diabetic kidney disease progression-a narrative review. Papers, record 42787134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42787134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hyperglycaemia-induced molecular reprogramming of proximal tubular epithelial cells and its contribution to diabetic kidney disease progression-a narrative review.
- Journal
- Front Cell Dev Biol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-09-26
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41120011 | Upregulation of BNIP3 alleviates renal tubular cell injury by activating mitophagy in diabetic nephropathy. | Biochem Pharmacol | 2026 | https://conductscience.org/library/papers/41120011 | PubMed |
| 2 | 23733640 | Pathophysiology of the diabetic kidney. | Compr Physiol | 2011 | https://conductscience.org/library/papers/23733640 | PubMed |
| 3 | 30132524 | Renoprotection of dapagliflozin in human renal proximal tubular cells via the inhibition of the high mobility group box 1‑receptor for advanced glycation end products‑nuclear factor‑κB signaling pathway. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/30132524 | PubMed |
| 4 | 37625003 | Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression. | Diabetes Care | 2023 | https://conductscience.org/library/papers/37625003 | PubMed |
| 5 | 18511445 | Oxidative stress as a major culprit in kidney disease in diabetes. | Diabetes | 2008 | https://conductscience.org/library/papers/18511445 | PubMed |
| 6 | 40421989 | The relationship between periodontitis and proteinuria in chronic kidney disease: A review. | Med Oral Patol Oral Cir Bucal | 2025 | https://conductscience.org/library/papers/40421989 | PubMed |
| 7 | 39792148 | Pax inhibition: stressing proximal tubule for successful repair. | Am J Physiol Renal Physiol | 2025 | https://conductscience.org/library/papers/39792148 | PubMed |
| 8 | 32982978 | Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32982978 | PubMed |
| 9 | 33424763 | Acute Hyperglycemia May Induce Renal Tubular Injury Through Mitophagy Inhibition. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33424763 | PubMed |
| 10 | 29520581 | Biomarkers of diabetic kidney disease. | Diabetologia | 2018 | https://conductscience.org/library/papers/29520581 | PubMed |
| 11 | 20458318 | Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. | Nat Biotechnol | 2010 | https://conductscience.org/library/papers/20458318 | PubMed |
| 12 | 31116062 | Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold. | J Histochem Cytochem | 2019 | https://conductscience.org/library/papers/31116062 | PubMed |
| 13 | 27165830 | Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. | Kidney Int | 2016 | https://conductscience.org/library/papers/27165830 | PubMed |
| 14 | 31506348 | The single-cell transcriptomic landscape of early human diabetic nephropathy. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31506348 | PubMed |
| 15 | 36856116 | Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors. | J Clin Invest | 2023 | https://conductscience.org/library/papers/36856116 | PubMed |
| 16 | 29181712 | Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. | Pediatr Nephrol | 2019 | https://conductscience.org/library/papers/29181712 | PubMed |
| 17 | 33190567 | Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/33190567 | PubMed |
| 18 | 39237549 | Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease. | Nat Commun | 2024 | https://conductscience.org/library/papers/39237549 | PubMed |
| 19 | 37468583 | An atlas of healthy and injured cell states and niches in the human kidney. | Nature | 2023 | https://conductscience.org/library/papers/37468583 | PubMed |
| 20 | 23390498 | Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy? | PLoS One | 2013 | https://conductscience.org/library/papers/23390498 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BGN | 633 | PubTator's text mining | https://conductscience.org/library/genes/633 | NCBI Gene |
| BNIP3 | 664 | PubTator's text mining | https://conductscience.org/library/genes/664 | NCBI Gene |
| ENPP1 | 5167 | PubTator's text mining | https://conductscience.org/library/genes/5167 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
| SOX9 | 6662 | PubTator's text mining | https://conductscience.org/library/genes/6662 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42787134
GET https://conductscience.org/api/papers/v1/42787134/references?page=2